Biotech Values

[poorgradstudent]

SRPT:

For me, D started my skepticism. But from what I could observe on the outside (never any position), the company definitely used F to their advantage because young children are impacted. We can argue whether or not the company was explicit in pushing this angle, but it was interesting to see many skeptical biotech traders and investors in my Twitter feed re-tweeting the daily progression of a few of the kids in the trial. I think many people became rapidly invested emotionally in the story.